BHPian prajakt_23 recently shared this with other enthusiasts:Part-I Please bear with me for a slightly lengthy beginning, ...

Precision Medicine Is the Future Of Healthcare When it comes to applied hard sciences, a source of progress has been more precise measurements and tools. This is especially true in physics and ...

[paper] [EMNLP-16]: Recursive Neural Conditional Random Fields for Aspect ... [paper] [ACL-19]: Exploring Sequence-to-Sequence Learning in Aspect Term Extraction. [paper] [ACL-19]: DOER: Dual ...

In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes through) become one company, combining Recursion’s expertise in biology with Exscientia’s focus on chemistry.

In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...